CCAP (Crescent Capital BDC) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


CCAP Crescent Capital BDC Inc CCAP
49 GF Score
Price $11.10
GF Value $6.79
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Crescent Capital BDC Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Crescent Capital BDC's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

CCAP vs DFP, EVN, FINS: Margin of Safety % (DCF FCF Based) Comparison

For the Asset Management subindustry, Crescent Capital BDC's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescent Capital BDC Margin of Safety % (DCF FCF Based) vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Crescent Capital BDC's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Crescent Capital BDC's Margin of Safety % (DCF FCF Based) falls into.


CCAP
49GF Score
Crescent Capital BDC Inc CCAP
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Crescent Capital BDC (CCAP) Overvalued in 2026?

Based on GuruFocus' analysis, Crescent Capital BDC stock appears to be overvalued. The current stock price of $11.10 is trading 63.5% above its estimated GF Value™ of $6.79. GuruFocus considers Crescent Capital BDC to be Significantly Overvalued.

Key valuation signals for CCAP:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $6.79 vs. price of $11.10 (63.5% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the CCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crescent Capital BDC Business Description

Other Exchanges 487:Germany
Address 11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
49GF Score

Get the complete analysis for CCAP

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.10
Price
$6.79
GF Value